Comprehensive Development and Manufacturing Support

We provide end-to-end development and manufacturing support to global generic and innovator companies , covering the complete product lifecycle from early-stage route scouting and process development to scale-up, commercial manufacturing, and support regulatory submissions.

Integrated development and manufacturing for generics and innovators:

From route scouting to scale-up

Commercial manufacturing & regulatory submissions

Strategic long-term partnership

Our Process:
Tailor-Made Chemistry for Specialised Needs

Pre-Clinical

  • Route selection
  • Process development
  • Analytical development

Phase II

  • Solid state characterization
  • Quality by Design (QbD) approach
  • Determination of critical process parameters (CPP)
  • Identification of critical quality attributes (CQA)

Commercial

  • Product release & retention
  • Lifecycle management
  • IP protection
  • Extensive batch size range: 0.1 kg to 1,000 kg

Phase I

  • Technology transfer
  • Analytical validation
  • Reference standard & impurity qualification
  • Preliminary stability studies

Phase III

  • Process validation
  • ICH stability studies
  • CMC regulatory support

Our Process:
Tailor-Made Chemistry for Specialised Needs

Pre-Clinical

  • Route selection
  • Process development
  • Analytical development

Phase I

  • Technology transfer
  • Analytical validation
  • Reference standard & impurity qualification
  • Preliminary stability studies

Phase II

  • Solid state characterization
  • Quality by Design (QbD) approach
  • Determination of critical process parameters (CPP)
  • Identification of critical quality attributes (CQA)

Phase III

  • Process validation
  • ICH stability studies
  • CMC regulatory support

Commercial

  • Product release & retention
  • Lifecycle management
  • IP protection
  • Extensive batch size range: 0.1 kg to 1,000 kg

Our Goal

At every development stage, our goal is to ensure a robust, safe, and scalable process supported by strong analytical methods and regulatory alignment.

Our Custom Synthesis Strengths:

Phase I

  • Robust and safe process
  • Route suitability, discrete parameters, impurity control (organic, mutagenic)
  • Analytical methods for SMs, IMs, and API; Validation of API analytical methods

Phase II

  • Target to select SMs, synthesis route & discrete parameters after Phase II campaigns
  • Continued impurity studies, physical characterization, crystallization & milling studies
  • Analytical development for SMs, IMs, and API; Validation of API methods

Phase III

  • Optimization of process parameters (DoE as needed)
  • Critical parameters, NOR & PAR determination
  • ICH-level validation of analytical methods

Commercial

  • Finalisation of the process
  • Process validation & lifecycle management
  • Finalisation and validation of analytical methods for SMs, IMs & API

Integrated Infrastructure and Flexible Manufacturing Solutions

Backed by integrated R&D, AR&D, IPM, and GMP manufacturing infrastructure, we deliver customized solutions aligned with customer-specific requirements, timelines, and market strategies. Our multi purpose facilities support flexible batch sizes from grams to multi tons with seamless technology transfer, ensuring smooth progression from laboratory to commercial scale.

Built for Flexibility, Scale & Speed

IP Protection Quality Control Quality Assurance Regulatory Affairs

Robust IP protection frameworks, strong data integrity systems, and confidentiality-driven processes ensure secure handling of customer-owned projects. With a strong focus on quality, regulatory compliance, and cost efficiency, we support filings across regulated and semi-regulated markets while ensuring reliable and consistent supply.

Secure, Compliant & Regulatory-Ready

Regulatory Documentation and Market Authorization Support

In addition, our regulatory team actively supports customers with API-related documentation for finished dosage form filings and provides technical assistance required for Marketing Authorization (MA) grant with global regulatory agencies.

A Collaborative and Scalable Partnership Model

This collaborative and scalable CDMO model positions Megafine as a trusted long-term partner, helping customers accelerate development, optimize manufacturing costs, and confidently bring products to global markets.

Strategic Investments for Long-Term Partnerships

We have and continue to consider new investments based on customer demand and well-defined business cases, enabling long-term and strategic partnerships.

Our regulatory support:

Regulatory Approvals

Other Capabilities

Contact us!

Get in touch with us

Get in touch with us